Minority Health Products and Services Firm of the Year is presented to Anpac Bio-Medical Science Company. Co-founded in 2010 by Chinese-American scientists Dr. Chris Yu and Dr. Herbert Yu, Anpac Bio is the only liquid biopsy services company fully-commercialized and earning revenue worldwide.
The company’s proprietary “Cancer Differentiation Analysis” (CDA) medical devices and liquid biopsy screening services effectively reinvented early cancer detection. Anpac Bio has filed more than 250 CDA-related patents globally and continues to significantly invest in R&D, patent filings, and partnership growth.
Today, the company has more than 150 employees, maintains nine operation sites worldwide, and is conservatively valued at approximately $200 million.
Posted at 3:07 PM
